Skip to main content
Log in

Transport of Dopamine at the Blood-Brain Barrier of the Guinea Pig: Inhibition by Psychotropic Drugs and Nicotine

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. Transport of dopamine (DA) across the blood-brain barrier (BBB) was examined in guinea pigs.

Methods. In situ brain perfusion (1–10 min), capillary depletion, and high pressure liquid chrbmatography (HPLC) were used.

Results. There was a saturable DA influx into the brain with a KM of 389 ± 55 nM, and a VMAXof 1.95 ± 0.25 pmol/min/g of brain. The diffusion constant, KD, was not significantly different from zero. About 0.5% of DA remained tightly bound to cerebral microvessels isolated from the perfused brain. DA influx into the brain was not altered by the monoamine oxidase-B (MAO-B) inhibitor pargyline (50 µM). HPLC analysis of perfused brain confirmed transport of intact DA, and no detectable increases in DA metabolites were observed. At perfusate concentrations of 500 nM, several dopaminergic receptor antagonists inhibited [3H]-DA (21 nM) influx; the percent inhibitions for the mixed D1 and D2 antagonists haloperidol and chlorpromazine, the D1, antagonist SCH-23390, and the D2 antagonist spiperone were 90%, 68%, 77%, and 50%, respectively. Brain perfusion with nicotine (500 nM) inhibited DA uptake by 86%. This nicotine effect was not altered by mecamylamine, but was partially prevented by the nicotinic receptor antagonist hexamethonium.

Conclusions. a) A significant cerebrovascular permeability to intact DA is mediated by a MAO-B independent specific transport system at the BBB, b) this system could be inhibited by D1, and D2 DA receptor antagonists, and c) DA blood-to-brain transport was inhibited by nicotine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. M. A. Menza, L. I. Golbe, R. A. Cody, and N. E. Forman. Dopamine related personality traits in Parkinson's disease, Neurology 43:505–508 (1993).

    Google Scholar 

  2. D. J. Diehl and S. Gershon. The role of dopamine in mood disorders, Comprehensive Psychiatry 33(2):115–120 (1992).

    Google Scholar 

  3. W. H. Oldendorf. Brain uptake of radiolabeled amino acids, amines and hexoses after arterial injection, Am. J. Physiol. 221:1629–1638 (1971).

    Google Scholar 

  4. S. I. Harik, J. J. Riachi, R. N. Kalaria, and J. C. Lamanna. The role of the blood-brain barrier in preventing MPTP toxicity. In B. B. Johansson, C. Owman, and H. Widner (eds), Pathophysiology of the Blood-Brain Barrier, Elsevier Science Publishers, Cambridge, 1990, pp. 255–267.

    Google Scholar 

  5. C. L. Martel, J. B. Mackic, M. H. Weiss, J. G. McComb, and B. V. Zlokovic. Transport and binding of circulating dopamine at the blood-brain barrier in guinea pigs, Soc. Neurosci. Abstr. 19:695 (1993).

    Google Scholar 

  6. B. V. Zlokovic. Cerebrovascular permeability to peptides: manipulations of transport systems at the blood-brain barrier, Pharmaceut. Res. 12:1395–1406 (1995).

    Google Scholar 

  7. F. Basic, S. Uematsu, R. M. McCarron, and M. Spatz. Dopaminergic receptors linked to adenylate cyclase in human cerebromicro-vascular endothelium, J. Neurochem. 57:1774–1780 (1991).

    Google Scholar 

  8. S. Grady, M. J. Marks, S. Wonnacott, and A. C. Collins. Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum, J. Neurochem. 59:848–856 (1992).

    Google Scholar 

  9. H. Yamashita, S. Kitayama, Y.-X Zhang, T. Takahashi, T. Dohi, and S. Nakamura. Effects of nicotine on dopamine uptake in COS cells possessing the rat dopamine transporter and in PC12 cells, Biochem. Pharmacol. 49:742–745 (1995).

    Google Scholar 

  10. D. Triguero, J. Buciak, and W. M. Pardridge. Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins, J. Neurochem. 54:1882–1888 (1990).

    Google Scholar 

  11. P. W. Kalivas. Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. II. Involvement of the mesolimbic dopamine system, J. Pharmacol. Exp. Ther. 235:544–550 (1985).

    Google Scholar 

  12. T. Suhara, K. Nakayama, O. Inoue, H. Fukuda, M. Shimizu, A. Mori, and Y. Tateno. D1 dopamine receptor binding in mood disorders measured by positron emission tomography, Psychopharm. 106:14–18 (1992).

    Google Scholar 

  13. J. L. Corey, M. W. Quick, N. Davidson, H. A. Lester, and J. Guastella. A cocaine-sensitive Drosophila serotonin transporter: cloning, expression, and electrophysiological characterization, Proc. Natl. Acad. Sci. USA 91: 1188–1192 (1994).

    Google Scholar 

  14. M. A. Hediger, Y. Kanai, G. You, and S. Nussberger. Mammalian ion-coupled solute transporters, J. Physiol. 482:7S–17S (1995).

    Google Scholar 

  15. B. Greenwood, E. Blank, and W. J. Dodds. Nicotine stimulates esophageal peristaltic contractions in cats by a central mechanism, Am. J. Physiol. 262:G567–G571 (1992).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Martel, C.L., Mackic, J.B., Adams, J.D. et al. Transport of Dopamine at the Blood-Brain Barrier of the Guinea Pig: Inhibition by Psychotropic Drugs and Nicotine. Pharm Res 13, 290–295 (1996). https://doi.org/10.1023/A:1016007601794

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016007601794

Navigation